Evidence map›Paper›PMID 32330308›Full record

ArticleBritish journal of haematology2020

COVID19 coagulopathy in Caucasian patients.

Helen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Paul Browne, Christopher L Bacon, Richard Gaule, Alexander Gillett, Mary Byrne and 5 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04470583 (Evaluation of Clinical Parameters Following COVID-19 Infection in Pregnancy), which is not on this map. Cited by 200 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
200citing papers in PubMed, 11 pooled it
10.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04470583 unknown statusnot on this map

Evaluation of Clinical Parameters Following COVID-19 Infection in Pregnancy (COpregVID)

TypeobservationalSponsorChelsea and Westminster NHS Foundation TrustRan2020 to 2021Enrolled116ConditionsCOVID-19, 2019 Novel Coronavirus Infection, COVID-19 Infection
3 · Its place in the literature

Who cites it

200 citing papers in PubMed, 11 syntheses or guidelines pooled it, 422 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Guideline
  11. Pooled it
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Immunity and Coagulation in COVID-19.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
  20. Observational

140 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Helen FogartyIrish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Liam TownsendDepartment of Infectious Diseases, St James's Hospital, Trinity College Dublin, Dublin, Ireland.
Cliona Ni CheallaighDepartment of Infectious Diseases, St James's Hospital, Trinity College Dublin, Dublin, Ireland.
Colm BerginDepartment of Infectious Diseases, St James's Hospital, Trinity College Dublin, Dublin, Ireland.
Ignacio Martin-LoechesIrish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Paul BrowneSt James's Hospital, Trinity College Dublin, Dublin, Ireland.
Christopher L BaconSt James's Hospital, Trinity College Dublin, Dublin, Ireland.
Richard GauleSt James's Hospital, Trinity College Dublin, Dublin, Ireland.
Alexander GillettSt James's Hospital, Trinity College Dublin, Dublin, Ireland.
Mary ByrneNational Coagulation Centre, St James's Hospital, Dublin, Ireland.
Kevin RyanNational Coagulation Centre, St James's Hospital, Dublin, Ireland.
Niamh O'ConnellNational Coagulation Centre, St James's Hospital, Dublin, Ireland.
Jamie M O'SullivanIrish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Niall ConlonDepartment of Immunology, St James's Hospital, Trinity College Dublin, Dublin, Ireland.
James S O'DonnellIrish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.ORCID 0000-0003-0309-3313
Trinity College Dublin · IERoyal College of Surgeons in Ireland · IESt. James's Hospital · IE

Funding

Zimmerman Program on the Biology of VWDP01HL144457 · NHLBI · VERSITI WISCONSIN, INC. · PI MONTGOMERY, ROBERT R · 2019 to 2023
$13.3M
Health and Social Care, Research and Development Division, Northern IrelandHealth Research Board 203930/B/16/ZHealth Research Board Investigator ILP-POR-2017-008Health Service Executive, National Doctors Training and PlanningNational Children's Research Centre C/18/1NHLBI NIH HHS P01 HL144457Science Foundation Ireland Principal Investigator 11/PI/1066Wellcome Trust
6 · The paper itself

Abstract

Although the pathophysiology underlying severe COVID19 remains poorly understood, accumulating data suggest that a lung-centric coagulopathy may play an important role. Elevated D-dimer levels which correlated inversely with overall survival were recently reported in Chinese cohort studies. Critically however, ethnicity has major effects on thrombotic risk, with a 3-4-fold lower risk in Chinese compared to Caucasians and a significantly higher risk in African-Americans. In this study, we investigated COVID19 coagulopathy in Caucasian patients. Our findings confirm that severe COVID19 infection is associated with a significant coagulopathy that correlates with disease severity. Importantly however, Caucasian COVID19 patients on low molecular weight heparin thromboprophylaxis rarely develop overt disseminated intravascular coagulation (DIC). In rare COVID19 cases where DIC does develop, it tends to be restricted to late-stage disease. Collectively, these data suggest that the diffuse bilateral pulmonary inflammation observed in COVID19 is associated with a novel pulmonary-specific vasculopathy termed pulmonary intravascular coagulopathy (PIC) as distinct to DIC. Given that thrombotic risk is significantly impacted by race, coupled with the accumulating evidence that coagulopathy is important in COVID19 pathogenesis, our findings raise the intriguing possibility that pulmonary vasculopathy may contribute to the unexplained differences that are beginning to emerge highlighting racial susceptibility to COVID19 mortality.

Indexed as

BetacoronavirusWhite PeopleBlood Coagulation DisordersCoronavirus InfectionsCOVID-19Disseminated Intravascular CoagulationFemaleHeparin, Low-Molecular-WeightHumansLungMaleMiddle AgedPandemicsPneumoniaPneumonia, ViralSARS-CoV-2Heparin, Low-Molecular-Weightcoagulation parameterCOVID19D-dimernovel coronavirus pneumonia

Identifiers

PMID32330308
PMCPMC7264579
OpenAlexW3019046211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.